127 related articles for article (PubMed ID: 38891801)
1. Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics.
Bărar AA; Pralea IE; Maslyennikov Y; Munteanu R; Berindan-Neagoe I; Pîrlog R; Rusu I; Nuțu A; Rusu CC; Moldovan DT; Potra AR; Tirinescu D; Ticala M; Elec FI; Iuga CA; Kacso IM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891801
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats.
Finne K; Vethe H; Skogstrand T; Leh S; Dahl TD; Tenstad O; Berven FS; Reed RK; Vikse BE
Nephrol Dial Transplant; 2014 Dec; 29(12):2217-27. PubMed ID: 25129444
[TBL] [Abstract][Full Text] [Related]
3. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Profiling of the Human Substantia Nigra Proteome from Laser-capture Microdissected FFPE Tissue.
Griesser E; Wyatt H; Ten Have S; Stierstorfer B; Lenter M; Lamond AI
Mol Cell Proteomics; 2020 May; 19(5):839-851. PubMed ID: 32132230
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications.
Chen Q; Xu J; Liu L; Ye Q; Lin W; Liao Y; Gao R; Zhang X; Chen R; Xiong Y; Chen S; Ye X; Wei L
J Proteome Res; 2024 Jun; 23(6):2090-2099. PubMed ID: 38728052
[TBL] [Abstract][Full Text] [Related]
7. AMPK mediates regulation of glomerular volume and podocyte survival.
Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
10. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
11. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
12. Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli.
Satoskar AA; Shapiro JP; Bott CN; Song H; Nadasdy GM; Brodsky SV; Hebert LA; Birmingham DJ; Nadasdy T; Freitas MA; Rovin BH
Mod Pathol; 2012 May; 25(5):709-21. PubMed ID: 22282304
[TBL] [Abstract][Full Text] [Related]
13. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
15. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
Embry AE; Liu Z; Henderson JM; Byfield FJ; Liu L; Yoon J; Wu Z; Cruz K; Moradi S; Gillombardo CB; Hussain RZ; Doelger R; Stuve O; Chang AN; Janmey PA; Bruggeman LA; Miller RT
J Am Soc Nephrol; 2018 May; 29(5):1501-1512. PubMed ID: 29572404
[No Abstract] [Full Text] [Related]
16. Proteome analysis of laser microdissected glomeruli from formalin-fixed paraffin-embedded kidneys of autopsies of diabetic patients: nephronectin is associated with the development of diabetic glomerulosclerosis.
Nakatani S; Wei M; Ishimura E; Kakehashi A; Mori K; Nishizawa Y; Inaba M; Wanibuchi H
Nephrol Dial Transplant; 2012 May; 27(5):1889-97. PubMed ID: 22172726
[TBL] [Abstract][Full Text] [Related]
17. Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies.
Aparecida Ferreira V; Aparecida da Silva C; Rodrigues do Carmo Neto J; Rocha LP; Monteiro Dos Santos Martins AL; Antônia Dos Reis M; Machado JR
Ann Diagn Pathol; 2024 Jun; 70():152292. PubMed ID: 38484478
[TBL] [Abstract][Full Text] [Related]
18. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
20. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
